Infection Surveillance Services Market

Infection Surveillance Services Market Overview:

The global infection surveillance services market size was valued at $407.06 million in 2020, and is projected to reach $1,724.22 million by 2030, registering a CAGR of 14.5% from 2021 to 2030. Infection surveillance service is defined as the service used to measure the success of infection prevention and control programs to identify the area of improvement. The infection surveillance service offers and collects the national data, which are used in benchmarking rates of surgical site infection. It is designed to continuously monitor and interpret the data related to health to ensure accurate implementation of preventive measures.

The COVID-19 outbreak is anticipated to have a positive impact on the growth of the global infection surveillance services market. The COVID-19 pandemic has stressed the healthcare systems in the world and increased the risk of developing healthcare-associated infection among COVID-19 patients.

The growth of the global infection surveillance services market is majorly driven by increase in prevalence of healthcare associated infection, rise in funding from private & government organizations for various programs related to infection surveillance, surge in number of surgical procedures, surge in geriatric population which is more susceptible to healthcare-associated infections, and rise in adoption of infection surveillance software among healthcare workers. According to the Centers for Disease Control and Prevention (CDC), it was reported that approximately 1.7 million infections and 99,000 deaths are reported for healthcare-associated infection, in the U.S., every year. For instance, in 2020, BioMerieux, a global leader in the field of in vitro diagnostics for infectious disease, announced the launch of CLARION, which is an infectious disease diagnostics software-as-a-service (SaaS) solution and connect diagnostic data in the U.S.. In addition, rise in resistance of microbes toward antibiotics fuels the market growth. According to the Association of Medical Microbiology and Infectious Disease Canada, in 2019, it was reported that healthcare-associated infectious diseases in Canada were caused due to prolonged use of antibiotics for Lyme disease. Furthermore, in June 2021, the European Centre for Disease Prevention and Control announced the launch of the European surveillance portal, EpiPulse for infectious disease. It aims to collect, share, and analyze the data of infectious diseases for further monitoring services. 

However, high cost of software associated with infection surveillance services is expected to restrict the market growth during the forecast period.

Infection Surveillance Services Market Segmentation

The infection surveillance services market is segmented into offering, infection type, end user, and region. By offering, the market is categorized into software and services. The software segment is further classified into on-premise and web-based. The services segment is subdivided into product support & maintenance services, training & consulting services, and implementation services. On the basis of infection type, the market is segregated into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others.

Depending end user, the market is fragmented into hospitals & clinics, ambulatory surgical centers & academic institutes, and long-term care facilities.

Region-wise, the infection surveillance services market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Segment review

Depending on offering, the software segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of healthcare-associated infection and increase in demand for infection surveillance software by healthcare sectors. However, the services segment is expected to witness considerable infection surveillance services market growth during the forecast period, owing to increase in demand for services used in hospital, rise in prevalence of hospital-acquired infection, and rise in adoption of infection surveillance software among healthcare workers.

On the basis of infection type, the surgical site infections acquired the largest share of infection surveillance services market in the year 2020. The growth of this segment is due to factors such as surge in the number of surgical procedures performed across the globe which in turn lead to rise in risk of surgical site infections. In addition, hospital acquired pneumonia segment is expected to exhibit fastest growth rate during the forecast period. The high growth rate of this segment is due to the increase in use of mechanical ventilation in patients hospitalized in intensive care units. Furthermore, it is also attributed to an aging population, and the introduction of sophisticated surgical procedures for treatment of neurological, oncological and other critical illness. Hence, this in turn leads to rise in risk for hospital acquired pneumonia which drives the growth of the market.

On the basis of end user, the hospital & clinics segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of healthcare-associated infection and surge in demand for electronic medical record. However, long-term care facilities segment is expected to witness considerable growth during the forecast period, owing to increase in in number of surgeries, rise in prevalence of surgical site infections, and surge in demand for effective management of infection.

North America accounted for a major share in the infection surveillance services market in 2020, and is expected to maintain its dominance during the forecast period, owing to rise in prevalence of healthcare-associated infections, presence of key players, increase in healthcare expenditure, advancements in analytical & infectious surveillance solution, and rise in government initiatives to prevent healthcare-associated infections in the region. However, Asia-Pacific is expected to register highest CAGR of 16.6% from 2021 to 2030, due to increase in prevalence of hospital-acquired infection, rise in geriatric population, increase in trend of self-medication, and rise in adoption of infection surveillance software among healthcare workers.

The key players operating in the global infection surveillance services market include Alpha Source Inc., Baxter International Inc., Becton, Dickinson and Company, BioVigil, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., RLDatix, S. C. Johnson & Son, Inc., and Wolters Kluwer.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the infection surveillance services market, and the current trends and future estimations to elucidate imminent investment pockets.
• It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing infection surveillance services market opportunities.
• Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Key Market Segments

By Offering

• Software
  • On-premise
  • Web-based
• Services
  • Product Support & Maintenance Services
  • Training & Consulting Services
  • Implementation Services

By Infection Type

• Hospital-acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTIs)
• Others

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers & Academic Institutes
• Long-term Care Facilities

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players 

• Alpha Source Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• BioVigil
• Gojo Industries Inc.
• International Business Machines Corporation
• Premier Inc.
• RLDatix
• S. C. Johnson & Son, Inc.
• Wolters Kluwer

 Infection Surveillance Services Market Report Highlights